• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Gold Market
Gold News
Gold Stocks
Gold Price
  • Gold Market
  • Gold News
  • Gold Stocks
  • Gold Price

Dalradian Resources Details Test Stoping Program

Teresa Matich
Apr. 06, 2016 09:42AM PST
Gold Investing

Dalradian Resources (TSX:DNA) provided details for its recently commenced test stoping program at the Curranhinalt gold deposit in Northern Ireland. The test program is part of ongoing work in support of a feasibility study for the project.

Dalradian Resources (TSX:DNA) provided details for its recently commenced test stoping program at the Curranhinalt gold deposit in Northern Ireland. The test program is part of ongoing work in support of a feasibility study for the project.
As quoted in the press release:

The program will commence on the V-75 vein, which is approximately 90 metres below the surface and 1,000 metres horizontally into the hillside at the deepest point of our development and therefore believed to be most representative for mining purposes of the bulk of the resource at Curraghinalt. The program will consist of a minimum of two test stopes averaging 1,000 tonnes each and may include up to four stopes. The test stoping program has been modified to include a ramp down of approximately 190 metres in length and 18 metres in depth to more accurately replicate planned mining techniques for a full-scale mine (refer to figures at www.dalradian.com/news-and-events/news-releases/news-releases-details/April-6-2016-News-Release-Figures for more details). The additional development has the advantage of including backfilling and provides the option to add up to two more stopes. The development completed to date has demonstrated sound rock mechanics and is yielding important data on the grade and metallurgical characteristics of the veins. Total development for Dalradian’s underground program is now expected to total 950-1000 metres, up from approximately 885 metres.
Preparatory development for the test stoping commenced in March and the stoping program should be completed during the second half of 2016. Definition drilling for the planned stopes is underway and is expected to be finished by the end of April. The expansion of the test stoping program is expected to have a negligible effect on the budget for the overall underground program as well as the anticipated timing for release of the FS, which remains in the second half of 2016.

Click here for the full press release.

tsx:dna
The Conversation (0)

Go Deeper

AI Powered
Mt Cattlin Ore Reserve update confirms mine life extension

Mt Cattlin Ore Reserve update confirms mine life extension

WESTERN COPPER AND GOLD ANNOUNCES METALLURGICAL PROGRAM AND ASSOCIATED DRILL RESULTS

WESTERN COPPER AND GOLD ANNOUNCES METALLURGICAL PROGRAM AND ASSOCIATED DRILL RESULTS

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES